← Eichor
Study identifier: NCT07553715 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia

Condition: Vulvodynia  ·  Sponsor: Nantes University Hospital

PhaseN/A
Planned participants50
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Vulvodynia is a chronic vulvar pain condition that can significantly affect quality of life. Low-intensity focal extracorporeal shock wave therapy has been proposed as a non-invasive therapeutic option, but real-world data remain limited. This retrospective observational study aims to evaluate the effectiveness of a four-session focal shock wave therapy protocol in women with vulvodynia treated in routine clinical practice at a university hospital. Clinical data collected during standard care, as well as questionnaire responses, will be analyzed to assess changes in symptoms and functional outcomes following treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa Bruckmann  ·  +33 2 40 16 50 58  ·  lisa.bruckmann@chu-nantes.fr

Alexandra Poinas, PhD  ·  +33 2 53 48 28 57  ·  alexandra.poinas@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Nantes- Allergy DepartmentNantes, Nantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07553715